153 related articles for article (PubMed ID: 38066445)
1. COVID-19 pandemic and initiation of treatment for atrial fibrillation: a nationwide analysis of claims data.
Yang L; Tang S; He M; Guo J; Gabriel N; Swabe G; Gellad WF; Essien UR; Saba S; Benjamin EJ; Magnani JW; Hernandez I
BMC Cardiovasc Disord; 2023 Dec; 23(1):604. PubMed ID: 38066445
[TBL] [Abstract][Full Text] [Related]
2. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 pandemic and trends in new diagnosis of atrial fibrillation: A nationwide analysis of claims data.
Hernandez I; He M; Guo J; Tadrous M; Gabriel N; Swabe G; Gellad WF; Essien UR; Saba S; Benjamin EJ; Magnani JW
PLoS One; 2023; 18(2):e0281068. PubMed ID: 36730318
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 and Anticoagulation for Atrial Fibrillation: An Analysis of US Nationwide Pharmacy Claims Data.
Hernandez I; Gabriel N; He M; Guo J; Tadrous M; Suda KJ; Magnani JW
J Am Heart Assoc; 2021 Dec; 10(24):e023235. PubMed ID: 34913359
[TBL] [Abstract][Full Text] [Related]
5. Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery.
Brochu D; St-Arnaud A; Marchand LÉ; Voisine P; Méthot J
J Cardiovasc Pharmacol Ther; 2022; 27():10742484221128124. PubMed ID: 36189934
[TBL] [Abstract][Full Text] [Related]
6. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
7. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
8. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
9. Global Oral Anticoagulation Use Varies by Region in Patients With Recent Diagnosis of Atrial Fibrillation: The GLORIA-AF Phase III Registry.
Bayer V; Kotalczyk A; Kea B; Teutsch C; Larsen P; Button D; Huisman MV; Lip GYH; Olshansky B
J Am Heart Assoc; 2022 Mar; 11(6):e023907. PubMed ID: 35243870
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and Safety of Direct Oral Anticoagulants in Relation to Temporal Changes in Their Use.
Lee SR; Choi EK; Kwon S; Jung JH; Han KD; Cha MJ; Oh S; Lip GYH
Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e005894. PubMed ID: 32160790
[TBL] [Abstract][Full Text] [Related]
11. Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOAC. A cohort study.
Martinez C; Katholing A; Wallenhorst C; Freedman SB
Thromb Haemost; 2016 Jan; 115(1):31-9. PubMed ID: 26246112
[TBL] [Abstract][Full Text] [Related]
12. Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study.
Mitchell A; Snowball J; Welsh TJ; Watson MC; McGrogan A
BMC Med; 2021 Aug; 19(1):189. PubMed ID: 34461899
[TBL] [Abstract][Full Text] [Related]
13. Implementation of oral anticoagulation treatment guidelines in patients with newly diagnosed atrial fibrillation.
Arbel A; Abu-Ful Z; Preis M; Cohen S; Saliba W
Br J Clin Pharmacol; 2021 Dec; 87(12):4747-4755. PubMed ID: 33982796
[TBL] [Abstract][Full Text] [Related]
14. Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: A population-based study.
Kezerle L; Tsadok MA; Berliner Senderey A; Hoshen M; Leventer-Roberts M; Reges O; Leibowitz M; Haim M
J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1356-1363. PubMed ID: 32212197
[TBL] [Abstract][Full Text] [Related]
15. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
Harrington J; Carnicelli AP; Hua K; Wallentin L; Patel MR; Hohnloser SH; Giugliano RP; Fox KAA; Hijazi Z; Lopes RD; Pokorney SD; Hong H; Granger CB
Circulation; 2023 Jun; 147(23):1748-1757. PubMed ID: 37042255
[TBL] [Abstract][Full Text] [Related]
16. Factors Associated with Anticoagulation Delay Following New-Onset Atrial Fibrillation.
Khurshid S; Weng LC; Hulme OL; Ellinor PT; Lubitz SA
Am J Cardiol; 2017 Oct; 120(8):1316-1321. PubMed ID: 28823487
[TBL] [Abstract][Full Text] [Related]
17. Use of oral anticoagulants in older people with atrial fibrillation in UK general practice: protocol for a cohort study using the Clinical Practice Research Datalink (CPRD) database.
Mitchell A; Welsh TJ; Watson MC; Snowball J; McGrogan A
BMJ Open; 2019 Dec; 9(12):e032646. PubMed ID: 31843842
[TBL] [Abstract][Full Text] [Related]
18. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
19. Disparities in oral anticoagulation initiation in patients with schizophrenia and atrial fibrillation: A nationwide cohort study.
Højen AA; Nielsen PB; Riahi S; Jensen M; Lip GYH; Larsen TB; Søgaard M
Br J Clin Pharmacol; 2022 Aug; 88(8):3847-3855. PubMed ID: 35355307
[TBL] [Abstract][Full Text] [Related]
20. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
